CCO Infectious Disease Podcast

423 Épisodes

1. How to Screen for Hepatitis Delta Virus

   Publié: 23/02/2023
2. Ensuring Linkage to Care for Patients Diagnosed With Hepatitis Delta Virus

   Publié: 23/02/2023
3. Questions Answered on ART Safety and Tolerability in Pregnant People and Transgender Individuals

   Publié: 23/02/2023
4. Australian Perspectives on Advances in HIV

   Publié: 17/02/2023
5. Perspectives From Latin America on Advances in HIV PrEP

   Publié: 17/02/2023
6. Canadian Perspectives on Advances in HIV Treatment and Prevention

   Publié: 17/02/2023
7. European Perspectives on Advances in HIV Treatment

   Publié: 17/02/2023
8. Diagnosis and Management of Patients With Long COVID

   Publié: 31/01/2023
9. The Role of College Campuses in HIV PrEP Uptake

   Publié: 31/01/2023
10. How Clinic Facilities Can Prepare for Long-Acting Injectable Antiretroviral Therapy

    Publié: 18/01/2023
11. Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

    Publié: 17/01/2023
12. Emerging Insights on Outpatient Management of Acute COVID-19 and Long COVID in Europe

    Publié: 13/01/2023
13. Administration of LA ART by Community Nurses in France

    Publié: 05/01/2023
14. PrEP Considerations for Transgender and Nonbinary Individuals

    Publié: 05/01/2023
15. Optimizing PrEP Selection and Persistence for MSM

    Publié: 05/01/2023
16. What Strategies Are Most Promising for Prevention and Treatment of Long COVID in Nonhospitalized Patients?

    Publié: 04/01/2023
17. Should We Be Concerned About Resistance and Development of New Variants With COVID-19 Antiviral Therapy?

    Publié: 04/01/2023
18. ART Selection in Treatment-Naive PWH: Weight Gain Considerations

    Publié: 30/12/2022
19. Should We Be Concerned About Viral Rebound With Antiviral Agents?

    Publié: 30/12/2022
20. Selecting First-line ART in Treatment-Naive Persons With HIV

    Publié: 29/12/2022